Marion Klaumuenzer

Statistics

Publications

Citations

H-Index

Active since

2012

Affiliations

Marion Klaumuenzer is an author at Heidelberg University specializing in molecular oncology, genome-wide copy number variation analysis, and kinase domain mutations.

Publications per year

2012–2024

Publications

The molecular interaction pattern of lenvatinib enables inhibition of wild-type or kinase-mutated FGFR2-driven cholangiocarcinoma

Stephan Spahn, Fabian Kleinhenz, Ekaterina Shevchenko et al. · Nature Communications · 2024 · 20 citations · Full text

Medicine, Oncology, Pharmacology +17

SNP array analysis of acute promyelocytic leukemia may be of prognostic relevance and identifies a potential high risk group with recurrent deletions on chromosomal subband 1q31.3

Daniel Nowak, Marion Klaumuenzer, Benjamin Hanfstein et al. · Genes Chromosomes and Cancer · 2012 · 16 citations

Life Sciences, Genetics, Hematology +17

1–2 of 2